Ribosomal protein S10 pseudogene 13 (RPS10P13)

Ribosomal protein S10 pseudogene 13 (RPS10P13) is classified as a pseudogene, meaning it is a non-functional genomic DNA sequence similar to the functional ribosomal protein S10 gene. RPS10P13 itself does not encode an active protein, and there is no evidence it serves as a direct therapeutic target, has known biological functions, or plays a role in human disease. Like other processed pseudogenes, it is a consequence of gene duplication or retrotransposition events and is not under selective evolutionary pressure, typically residing in regions of low recombination throughout the human genome[1][2][8][9]. Context and details: - RPS10P13 is linked to the parental ribosomal protein S10 gene (RPS10), a component of the 40S ribosomal subunit essential for protein synthesis[7][10]. - RPS10P13, as a pseudogene, is not known to be expressed as a functional protein, does not participate in canonical ribosomal processes, is not implicated in genetic disease, nor is it a drug target[1][2][8][9]. - The parent gene, ribosomal protein S10 (RPS10), is functionally distinct and involved in translation and certain diseases, but these properties do not extend to its pseudogenes such as RPS10P13[7][10]. - No relevant aliases exist beyond catalog identifiers. Thus, RPS10P13 does not constitute a therapeutic target and does not have ascribed biological or clinical relevance. It is best classified as a genomic pseudogene artifact with no known drug, biomarker, or safety characteristics.

Other names

RPS10_8_685RPS10P13